[ATX] QoQ Quarter Result on 30-Sep-2022 [#Q2]

Stock
[ATX] Amplia Therapeutics Limited
Announcement Date
29-Sep-2022
Financial Year
2023
Quarter
30-Sep-2022 [#Q2]
Profit Trend
QoQ- -25.41%
YoY- -120.11%
Quarter Report
ATX's Result
ATX's Financial Summary
View:
Show?
Quarter Result
31/03/24 30/09/23 31/03/23 30/09/22 31/03/22 30/09/21 31/03/21 CAGR
Revenue 2,004 2,448 -580 1,769 1,221 763 674 43.74%
PBT -5,364 -3,578 -2,751 -4,640 -3,542 -2,085 -2,444 29.92%
Tax -1,989 -2,448 580 -1,728 -1,221 -763 -674 43.38%
NP -3,374 -1,129 -3,331 -2,912 -2,322 -1,323 -1,770 23.96%
Tax Rate - - - - - - - -
Total Cost 5,379 3,578 2,751 4,681 3,542 2,085 2,444 30.04%
Ratio Analysis
31/03/24 30/09/23 31/03/23 30/09/22 31/03/22 30/09/21 31/03/21 CAGR
NP Margin -168.34 -46.12 574.35 -164.57 -190.17 -173.45 -262.76 -13.78%
Per Share
31/03/24 30/09/23 31/03/23 30/09/22 31/03/22 30/09/21 31/03/21 CAGR
EPS -0.02 -0.01 -0.02 -0.01 -0.01 -0.01 -0.02 0.00%
EPS Diluted -0.02 -0.01 -0.02 -0.01 -0.01 -0.01 -0.02 0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.